Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celldex Therapeutics (CLDX) Goodwill (2016 - 2017)

Historic Goodwill for Celldex Therapeutics (CLDX) over the last 8 years, with Q4 2017 value amounting to $91.0 million.

  • Celldex Therapeutics' Goodwill changed 0.0% to $91.0 million in Q4 2017 from the same period last year, while for Dec 2017 it was $91.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $91.0 million for FY2017, which is 0.0% changed from last year.
  • Celldex Therapeutics' Goodwill amounted to $91.0 million in Q4 2017, which was down 0.0% from $91.0 million recorded in Q3 2017.
  • Over the past 5 years, Celldex Therapeutics' Goodwill peaked at $91.0 million during Q4 2016, and registered a low of $9.0 million during Q1 2013.
  • Over the past 5 years, Celldex Therapeutics' median Goodwill value was $9.0 million (recorded in 2013), while the average stood at $29.5 million.
  • In the last 5 years, Celldex Therapeutics' Goodwill changed by 0.0% in 2013 and then skyrocketed by 91479.09% in 2016.
  • Over the past 5 years, Celldex Therapeutics' Goodwill (Quarter) stood at $9.0 million in 2013, then changed by 0.0% to $9.0 million in 2014, then changed by 0.0% to $9.0 million in 2015, then skyrocketed by 914.79% to $91.0 million in 2016, then changed by 0.0% to $91.0 million in 2017.
  • Its last three reported values are $91.0 million in Q4 2017, $91.0 million for Q3 2017, and $91.0 million during Q2 2017.